Axelys presents Quebec’s RNA ecosystem to investors at an event in Montreal
Over 70 guest gathered on January 28, 2026 at Ax.C for an event organized by Axelys, in collaboration with the CQDM and Montréal InVivo, as part of the AReNA initiative : Quebec’s RNA Ecosystem: Investment opportunity for the future. The day was punctuated by presentation, an investors’ round table’ panel, as well as moments for networking combining planned meetings and free discussions.
Facilitators and presentators
Axelys wholeheartedly thanks members and leaders of the organizations listed below, who generously offered their time, expertise and vision, making this event a constructive and invigorating one for everyone with eyes on the future of Quebec’s RNA therapies.
Key Themes
Focused on emerging technologies in RNA-based therapy and disruptive biotechnologies, the event brought together strategic players from the private and industrial sectors, international and Canadian venture capital investors, Quebec innovators, and AReNA’s public partners.
- AReNA mission and positioning
- Investors’ panel : Investing Early in Breakthrough Therapeutic Innovation
- Project showcase : Presentation of high impact technologies and emerging solutions
- How Québec De-Risks Innovation
RNA Technology Portfolio
High impact technologies and emerging solutions
- Full proposition and essential statistics
- Raised funds
- Milestones
- Business model and opportunities
- Market analyses
- Team members
Download the RNA Portfolio
PDF (12 pages)
Article
Sponsors
The cocktail was sponsored by the promotion and outreach partners involved with AReNA, Quebec’s RNA Hub : Axelys, the CQDM and Montréal Invivo.
Photos from January 28, 2026
Photos : Axelys / Tzara Maud
